SARASOTA, Fla., April 14, 2010 -- Sunovia Energy Technologies Inc. (OTCBB: SUNV), which designs, develops and markets highly efficient renewable energy and energy conservation products in the solar and LED lighting industries, plans to triple the size of its facility and add 68 employees over three years after relocating to Sarasota County this year.
Sunovia Energy Technologies Inc. closed at $0.084 Wednesday, trading 915,670 shares.
Sunovia Energy Technologies Plans to Triple Facility, Add 68 Employees in Move to Sarasota County
About Sunovia Energy Technologies, Inc.
Sunovia Energy Technologies is a Sarasota, FL-based cleantech company that develops and markets products within the LED lighting and solar markets that reduce carbon emissions, promote national security and preserve the environment.
Sunovia's LED lighting technologies have the highest Energy Star® Fitted Target Efficiency (FTE) ratings in the industry, and are among the most cost and energy-efficient in the world. The products are marketed under the brand name EvoLucia® (evolucialighting.com).
More information about Sunovia is available in Sunovia's Securities and Exchange filings at sec.gov, or at the company's Web sites, sunoviaenergy.com and evolucialighting.com.
For additional small cap news, tools and tips visit http://stockprofiler.us/?action=main.market_news
-------------------------------------------
GREENWOOD VILLAGE, Colo., April 14, 2010 -- Ampio Pharmaceuticals, Inc. (OTCBB: AMPE), today announced the appointment of Philip H. Coelho to its Board of Directors, effective immediately.
Ampio Pharmaceuticals, Inc. closed at $4.00 Wednesday, trading 5,405 shares.
Ampio Pharmaceuticals, Inc. Appoints New Independent Director
About Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The product pipeline includes new uses for previously approved drugs, some of which we expect will shortly start clinical trials, and new molecular entities ("NMEs"). By concentrating on development of new uses for previously approved drugs, approval timelines, costs and risk of clinical failure are reduced because these drugs have strong potential to be safe and effective while their shorter development times can significantly increase near-term value. A key strategy includes actively exploring partnership, licensing and other collaboration opportunities to maximize Ampio's product development programs.
For additional small cap news, tools and tips visit http://stockprofiler.us/?action=main.market_news
-------------------------------------------
StockProfiler.US Announcement!
Membership with access to enhanced stock investing tools is now FREE! Claim yours at http://stockprofiler.us/index.php?action=main.register
Stay connected with StockProfiler.US – Fan up with us on Facebook (keyword: StockProfiler.US) or follow us on Twitter at http://twitter.com/StockProfilerUS
View free small cap company videos and product reviews at our YouTube channel. Visit http://www.youtube.com/StockProfilerUS
-------------------------------------------
About StockProfiler.US:
StockProfiler.US is a media source for publicly traded small cap companies and investors to come together and discover market opportunities. Public companies can effectively broadcast their message to a targeted audience who come to StockProfiler.US seeking an advantage by discovering companies in their startup phase or ones who have yet to be discovered by the investment community.
Call us at (603) 424-4420 or email info@stockprofiler.us
-------------------------------------------
Please Note: All news contained herein has been previously issued by the companies mentioned in this release, and is the property of each company, respectively. All news is edited for content. The companies that are discussed in this opinion have not approved the statements made in this opinion.
This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.
Stock Profiler.US, LLC's News Division includes but is not limited to: http://www.stockprofiler.us, http://www.associatesfortune.com, http://www.fastmoneytalk.com, http://www.markettelegraph.com, http://www.thewallstreetleader.com, and http://www.daytradersdigest.com.
Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.
To view full disclaimers and terms of use, go to http://stockprofiler.us/?action=main.disclaimer
-------------------------------------------
Keywords: small cap stock, small cap news, small cap stock alerts, small cap stock updates, small cap stock news updates, small cap stock profile
Posts
No comments:
Post a Comment